Clinical Trial Update: The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating gemcitabine plus nab-paclitaxel as secondary chemotherapy in advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Pancreatic Adenocarcinoma, Chemotherapy Effect | Phase 4 | Status: UNKNOWN